Testing effectiveness (Phase 2)Study completedNCT05535569
What this trial is testing
Phase Ib/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With Paclitaxel in Epstein-Barr Virus(EBV)-Related, or Microsatellite Instability-High (MSI-H), or Programmed Cell Death Ligand 1 (PD-L1) Positive Advanced Gastric Cancer
Who this might be right for
Recurrent/Metastatic Gastric Cancer
Yonsei University 50